Literature DB >> 32671562

Evaluation of the effects of integrative non-pharmacological interventions on the internal coherence and resilience of breast cancer patients.

Shiao Li Oei1, Anja Thronicke2, Harald Matthes2,3, Friedemann Schad2,4.   

Abstract

PURPOSE: In the breast cancer center at the Gemeinschaftskrankenhaus Havelhöhe (GKH), integrative strategies are implemented in the routine care of breast cancer patients. The aim of this breast cancer real-world study was to systematically evaluate changes in patients' internal coherence and resilience, associated with the use of non-pharmacological interventions (NPIs).
METHODS: This study included 231 primary breast cancer patients treated with standard oncological therapy and NPIs, which comprise art and movement therapies, nursing interventions, and educational components, and had answered the internal coherence scale (ICS) questionnaire at first diagnosis and 12 months later. Data were collected from the Network Oncology clinical registry of the GKH, and effects of NPIs on ICS changes were analyzed with adjusted linear multivariable regression analyses, using the software R.
RESULTS: Two hundred twenty breast cancer patients of all tumor stages were eligible for a total of 27 separate adjusted multivariable linear regression analyses. The NPIs elaborate consultations and life review (ECLR); nursing compresses, music therapy, and rhythmic massages were significantly associated with increases of about 2-point changes in inner resilience and coherence (p < 0.05). Furthermore, a significant association with an elevation of the thermo coherence was observed for the application of nursing compresses.
CONCLUSIONS: The evaluation of real-world data carried out here shows that the application of the multimodal treatment concept can lead to an enhancement of the internal coherence and resilience in breast cancer patients. To improve the care of cancer patients, this multimodal program should be further expanded into routine clinical practices. TRIAL REGISTRATION: Trial registration number DRKS00013335 on 27/11/2017 retrospectively registered.

Entities:  

Keywords:  Breast cancer; Elaborate consultations and life review; Health-related quality of life; Integrative oncology; Internal coherence; Non-pharmacological interventions

Mesh:

Year:  2020        PMID: 32671562     DOI: 10.1007/s00520-020-05617-4

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  27 in total

Review 1.  Antonovsky's sense of coherence scale and its relation with quality of life: a systematic review.

Authors:  Monica Eriksson; Bengt Lindström
Journal:  J Epidemiol Community Health       Date:  2007-11       Impact factor: 3.710

2.  Integrative cancer care in a certified Cancer Centre of a German Anthroposophic hospital.

Authors:  Anja Thronicke; Shiao Li Oei; Antje Merkle; Cornelia Herbstreit; Hans-Peter Lemmens; Christian Grah; Matthias Kröz; Harald Matthes; Friedemann Schad
Journal:  Complement Ther Med       Date:  2018-04-04       Impact factor: 2.446

3.  Psychosocial, Cognitive, and Physical Impact of Elaborate Consultations and Life Review in Female Patients with Non-Metastasized Breast Cancer.

Authors:  Anja Thronicke; Matthias Kröz; Antje Merkle; Harald Matthes; Cornelia Herbstreit; Friedemann Schad
Journal:  Complement Med Res       Date:  2018-04-18       Impact factor: 1.211

4.  Implementation of an Integrative Oncological Concept in the Daily Care of a German Certified Breast Cancer Center.

Authors:  Friedemann Schad; Anja Thronicke; Antje Merkle; Megan L Steele; Matthias Kröz; Cornelia Herbstreit; Harald Matthes
Journal:  Complement Med Res       Date:  2018-03-07       Impact factor: 1.211

Review 5.  Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.

Authors:  Heather Greenlee; Melissa J DuPont-Reyes; Lynda G Balneaves; Linda E Carlson; Misha R Cohen; Gary Deng; Jillian A Johnson; Matthew Mumber; Dugald Seely; Suzanna M Zick; Lindsay M Boyce; Debu Tripathy
Journal:  CA Cancer J Clin       Date:  2017-04-24       Impact factor: 508.702

6.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

7.  Anthroposophic medicine: an integrative medical system originating in europe.

Authors:  Gunver S Kienle; Hans-Ulrich Albonico; Erik Baars; Harald J Hamre; Peter Zimmermann; Helmut Kiene
Journal:  Glob Adv Health Med       Date:  2013-11

8.  Individualized Integrative Cancer Care in Anthroposophic Medicine: A Qualitative Study of the Concepts and Procedures of Expert Doctors.

Authors:  Gunver S Kienle; Milena Mussler; Dieter Fuchs; Helmut Kiene
Journal:  Integr Cancer Ther       Date:  2016-05-04       Impact factor: 3.279

9.  Reliability and validity of a new scale on internal coherence (ICS) of cancer patients.

Authors:  Matthias Kröz; Arndt Büssing; Hans Broder von Laue; Marcus Reif; Gene Feder; Friedemann Schad; Matthias Girke; Harald Matthes
Journal:  Health Qual Life Outcomes       Date:  2009-06-24       Impact factor: 3.186

Review 10.  Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007.

Authors:  Ali Montazeri
Journal:  J Exp Clin Cancer Res       Date:  2008-08-29
View more
  2 in total

1.  Assessment of integrative non-pharmacological interventions and quality of life in breast cancer patients using real-world data.

Authors:  Shiao Li Oei; Anja Thronicke; Harald Matthes; Friedemann Schad
Journal:  Breast Cancer       Date:  2021-01-03       Impact factor: 4.239

2.  Analysis of Changes in Cancer-Related Fatigue of Breast Cancer Patients Receiving an Integrative Medicine Program.

Authors:  Friedemann Schad; Anja Thronicke; Phillipp von Trott; Shiao Li Oei
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.